Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial

PURPOSE: Oral adsorbents delay disease progression and improve uremic symptoms in patients with chronic kidney disease (CKD). DW-7202 is a newly developed oral adsorbent with high adsorptive selectivity for uremic toxins. We evaluated patient preference for and adherence to DW-7202 versus AST-120 th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Yonsei Med J
Prif Awduron: Kee, Youn Kyung, Han, Sang Youb, Kang, Duk-Hee, Noh, Jung Woo, Jeong, Kyung Hwan, Kim, Gheun-Ho, Kim, Yang Wook, Kim, Beom Seok
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Yonsei University College of Medicine 2021
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7820454/
https://ncbi.nlm.nih.gov/pubmed/33381933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2021.62.1.41
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg